Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Mar 16, 2025; 17(3): 99540
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.99540
Published online Mar 16, 2025. doi: 10.4253/wjge.v17.i3.99540
Figure 2 Cumulative incidences of metachronous gastric cancer after curative endoscopic submucosal dissection between different risk factors.
A: The presence or absence of metabolic dysfunction-associated steatotic liver disease; B: Different Helicobacter pylori infection status; C: Degrees of mucosal atrophy; D: Differentiation of the lesions. MASLD: Metabolic dysfunction-associated steatotic liver disease; MGC: Metachronous gastric cancer; PD: Poorly differentiated; WD: Well differentiated; MD: Moderately differentiated.
- Citation: Xiang Y, Yuan Y, Wang ZY, Zhu YM, Li WY, Ye QG, Wang YN, Sun Q, Ding XW, Longi F, Tang DH, Xu GF. Comorbidities related to metachronous recurrence for early gastric cancer in elderly patients. World J Gastrointest Endosc 2025; 17(3): 99540
- URL: https://www.wjgnet.com/1948-5190/full/v17/i3/99540.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i3.99540